01Jun2021
Altaris Completes Partnership with Michelin and Acquires Majority Stake in Solesis
New York, NY—Altaris Capital Partners, LLC (collectively with its affiliates, “Altaris”) announced today that it has completed the acquisition of a 51% stake in Solesis LLC (“Solesis”) from Michelin. As part of the transaction, Michelin retained a 49% stake in Solesis,…
06May2021
Minnetronix Medical Recognized for Surgical Technology Innovation in 2021 MedTech Breakthrough Awards Program
St. Paul, MN—Minnetronix Medical, Inc., a leading medical technology partner to global medical device companies, today announced that its MindsEye™ Expandable Port has won the “Best New Technology Solution – Surgical” award in the fifth annual MedTech Breakthrough Awards program….
20Apr2021
Participation in SilverSneakers Leads to a Substantial Decrease in Overall Healthcare Costs and Improved Health Outcomes for Seniors
Nashville, TN—PRNewswire—Total average healthcare expenses are significantly reduced by 16% for SilverSneakers® participants compared to non-participating Medicare Advantage members, according to a new comprehensive scientific study. The study was conducted by well-respected healthcare consulting firm Avalere Health and released today…
15Apr2021
Altaris to Partner with Michelin and Acquire Majority Stake in Solesis
New York, NY—Altaris Capital Partners, LLC (collectively with its affiliates, “Altaris”) announced today that it has entered into an agreement with Michelin to acquire a 51% stake of Solesis, Inc. (“Solesis”). Following closing of the transaction, Michelin will retain a…
12Apr2021
Kindeva Appoints Greg Sargen to Board of Directors
St. Paul, MN—Kindeva Drug Delivery L.P. (Kindeva) announced that Greg Sargen has joined Kindeva’s Board of Directors. The appointment of Mr. Sargen is effective as of April 5, 2021. Mr. Sargen, with over 20 years of experience in the biopharmaceutical…
05Apr2021
Kindeva Drug Delivery and Cambridge Healthcare Innovations Limited to Collaborate on Development of Novel Dry-Powder Inhaler Product
St. Paul, MN—Kindeva Drug Delivery L.P. (Kindeva) and Cambridge Healthcare Innovations Limited (CHI) have entered into a collaboration to develop and commercialize CHI’s αeolus dry-powder inhaler (DPI) platform technology. The collaboration will leverage Kindeva’s product development, regulatory affairs, and manufacturing…
01Apr2021
Altaris Exits Senior Helpers
New York, NY—Altaris Capital Partners, LLC (“Altaris”) is pleased to announce that it has exited its investment in Senior Helpers through a transaction with Advocate Aurora Enterprises, a subsidiary of the not-for-profit, integrated health system Advocate Aurora Health. As part…
17Mar2021
Clearwater Extends Healthcare Cyber Risk Management Leadership with AI-Driven Predictive Risk Rating, Peer-to-Peer Benchmarking and ServiceNow Integration Capabilities
Nashville, TN—Clearwater, the leading provider of Enterprise Cyber Risk Management and HIPAA Compliance solutions for the healthcare industry, announced today new innovations being introduced as part of the forthcoming 6.0 release of its flagship software product IRM|Analysis. Focused on helping…
15Mar2021
Kindeva Seals Deal To Expand Operations at Charnwood Campus
Global contract development and manufacturing organisation (CDMO) Kindeva Drug Delivery has expanded its operations at Charnwood Campus, in a deal expected to support Kindeva’s continued growth in the UK. The US-headquartered company will take over a state-of-the-art research and development…
08Mar2021
Viatris Inc. and Kindeva Drug Delivery Announce FDA Tentative Approval of the First Generic Symbicort®
Pittsburgh, PA and St. Paul, MN—Viatris Inc. (NASDAQ: VTRS) and Kindeva Drug Delivery L.P. today announced that the U.S. Food and Drug Administration (FDA) granted tentative approval of budesonide/formoterol fumarate dihydrate products, the first generic version of Symbicort® based on…
01Mar2021
Altaris Capital Partners to Acquire Prescription Pharmaceuticals Business from Perrigo
New York, NY—Altaris Capital Partners, LLC (collectively with its affiliates, “Altaris”) announced today that it has entered into an agreement to acquire the prescription pharmaceuticals business (“Rx”) of Perrigo Company plc (NYSE; TASE: PRGO) for total consideration equal to approximately…
25Feb2021
Healthcare Industry Veteran Joins Clearwater as Vice President of Business Development
Nashville, TN—Clearwater, the leading provider of Enterprise Cyber Risk Management and HIPAA Compliance solutions for the healthcare industry, announced today that Will Pendleton has joined the company as Vice President, Business Development. In this new role, Mr. Pendleton will focus…